|
1
|
Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, Tan
M, Shan BE, Lu BF and Zhang XG: B7-H4 expression associates with
cancer progression and predicts patient's survival in human
esophageal squamous cell carcinoma. Cancer Immunol Immunother.
60:1047–1055. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen LJ, Zheng X, Shen YP, Zhu YB, Li Q,
Chen J, Xia R, Zhou SM, Wu CP, Zhang XG, et al: Higher numbers of
T-bet(+) intratumoral lymphoid cells correlate with better survival
in gastric cancer. Cancer Immunol Immunother. 62:553–561. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu Y, Chen L, Xu B, Xiong Y, Yang M, Rui
X, Shi L, Wu C, Jiang J and Lu B: Higher numbers of T-Bet+
tumor-infiltrating lymphocytes associate with better survival in
human epithelial ovarian cancer. Cell Physiol Biochem. 41:475–483.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu Y, Ju S, Chen E, Dai S, Li C, Morel P,
Liu L, Zhang X and Lu B: T-bet and eomesodermin are required for T
cell-mediated antitumor immune responses. J Immunol. 185:3174–3183.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pimenta EM and Barnes BJ: Role of tertiary
lymphoid structures (TLS) in anti-tumor immunity: Potential
tumor-induced cytokines/chemokines that regulate TLS formation in
epithelial-derived cancers. Cancers (Basel). 6:969–997. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singer M, Wang C, Cong L, Marjanovic ND,
Kowalczyk MS, Zhang H, Nyman J, Sakuishi K, Kurtulus S, Gennert D,
et al: A distinct gene module for dysfunction uncoupled from
activation in tumor-infiltrating T cells. Cell. 166:1500–1511.e9.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dieu-Nosjean MC, Antoine M, Danel C,
Heudes D, Wislez M, Poulot V, Rabbe N, Laurans L, Tartour E, de
Chaisemartin L, et al: Long-term survival for patients with
non-small-cell lung cancer with intratumoral lymphoid structures. J
Clin Oncol. 26:4410–4417. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Galon J, Costes A, Sanchez-Cabo F,
Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M,
Berger A, Wind P, et al: Type, density, and location of immune
cells within human colorectal tumors predict clinical outcome.
Science. 313:1960–1964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pagès F, Berger A, Camus M, Sanchez-Cabo
F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte
D, et al: Effector memory T cells, early metastasis, and survival
in colorectal cancer. N Engl J Med. 353:2654–2666. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goc J, Fridman WH, Sautès-Fridman C and
Dieu-Nosjean MC: Characteristics of tertiary lymphoid structures in
primary cancers. Oncoimmunology. 2:e268362013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang D, He W, Wu C, Tan Y, He Y, Xu B,
Chen L, Li Q and Jiang J: Scoring system for tumor-infiltrating
lymphocytes and its prognostic value for gastric cancer. Front
Immunol. 10:712019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martinet L, Filleron T, Le Guellec S,
Rochaix P, Garrido I and Girard JP: High endothelial venule blood
vessels for tumor-infiltrating lymphocytes are associated with
lymphotoxin beta-producing dendritic cells in human breast cancer.
J Immunol. 191:2001–2008. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cipponi A, Mercier M, Seremet T, Baurain
JF, Théate I, van den Oord J, Stas M, Boon T, Coulie PG and van
Baren N: Neogenesis of lymphoid structures and antibody responses
occur in human melanoma metastases. Cancer Res. 72:3997–4007. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Chaisemartin L, Goc J, Damotte D,
Validire P, Magdeleinat P, Alifano M, Cremer I, Fridman WH,
Sautès-Fridman C and Dieu-Nosjean MC: Characterization of
chemokines and adhesion molecules associated with T cell presence
in tertiary lymphoid structures in human lung cancer. Cancer Res.
71:6391–6399. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bergomas F, Grizzi F, Doni A, Pesce S,
Laghi L, Allavena P, Mantovani A and Marchesi F: Tertiary
intratumor lymphoid tissue in colo-rectal cancer. Cancers (Basel).
4:1–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Joshi NS, Akama-Garren EH, Lu Y, Lee DY,
Chang GP, Li A, DuPage M, Tammela T, Kerper NR, Farago AF, et al:
Regulatory T cells in tumor-Associated tertiary lymphoid structures
suppress anti-tumor T cell responses. Immunity. 43:579–590. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goc J, Germain C, Vo-Bourgais TK, Lupo A,
Klein C, Knockaert S, de Chaisemartin L, Ouakrim H, Becht E,
Alifano M, et al: Dendritic cells in tumor-associated tertiary
lymphoid structures signal a Th1 cytotoxic immune contexture and
license the positive prognostic value of infiltrating CD8+ T cells.
Cancer Res. 74:705–715. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu-Trantien C, Loi S, Garaud S, Equeter C,
Libin M, de Wind A, Ravoet M, Le Buanec H, Sibille C,
Manfouo-Foutsop G, et al: CD4+ follicular helper T cell
infiltration predicts breast cancer survival. J Clin Invest.
123:2873–2892. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gottlin EB, Bentley RC, Campa MJ, Pisetsky
DS, Herndon JE II and Patz EF Jr: The association of intratumoral
germinal centers with early-stage non-small cell lung cancer. J
Thorac Oncol. 6:1687–1690. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McHeyzer-Williams LJ and McHeyzer-Williams
MG: Antigen-specific memory B cell development. Annu Rev Immunol.
23:487–513. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bos R and Sherman LA: CD4+ T-cell help in
the tumor milieu is required for recruitment and cytolytic function
of CD8+ T lymphocytes. Cancer Res. 70:8368–8377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bos R, Marquardt KL, Cheung J and Sherman
LA: Functional differences between low- and high-affinity CD8(+) T
cells in the tumor environment. Oncoimmunology. 1:1239–1247. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kroenke MA, Eto D, Locci M, Cho M,
Davidson T, Haddad EK and Crotty S: Bcl6 and Maf cooperate to
instruct human follicular helper CD4 T cell differentiation. J
Immunol. 188:3734–3744. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang C, Hillsamer P and Kim CH: Phenotype,
effector function, and tissue localization of PD-1-expressing human
follicular helper T cell subsets. BMC Immunol. 12:532011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Petrovas C, Ferrando-Martinez S, Gerner
MY, Casazza JP, Pegu A, Deleage C, Cooper A, Hataye J, Andrews S,
Ambrozak D, et al: Follicular CD8 T cells accumulate in HIV
infection and can kill infected cells in vitro via bispecific
antibodies. Science translational medicine. 9:eaag22852017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He R, Hou S, Liu C, Zhang A, Bai Q, Han M,
Yang Y, Wei G, Shen T, Yang X, et al: Follicular CXCR5- expressing
CD8(+) T cells curtail chronic viral infection. Nature.
537:412–428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Galon J, Mlecnik B, Bindea G, Angell HK,
Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A, Bifulco C, et
al: Towards the introduction of the ‘Immunoscore’ in the
classification of malignant tumours. J Pathol. 232:199–209. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hennequin A, Derangère V, Boidot R, Apetoh
L, Vincent J, Orry D, Fraisse J, Causeret S, Martin F, Arnould L,
et al: Tumor infiltration by Tbet+ effector T cells and CD20+ B
cells is associated with survival in gastric cancer patients.
Oncoimmunology. 5:e10545982016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee HJ, Park IA, Song IH, Shin SJ, Kim JY,
Yu JH and Gong G: Tertiary lymphoid structures: Prognostic
significance and relationship with tumour-infiltrating lymphocytes
in triple-negative breast cancer. J Clin Pathol. 69:422–430. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Carney JA: Gastric mucosal lymphoid
follicles: Histology, distribution, frequency, and etiologic
features. Am J Surg Pathol. 34:1019–1024. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dieu-Nosjean MC, Giraldo NA, Kaplon H,
Germain C, Fridman WH and Sautes-Fridman C: Tertiary lymphoid
structures, drivers of the anti-tumor responses in human cancers.
Immunol Rev. 271:260–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Geng Y, Shao Y, He W, Hu W, Xu Y, Chen J,
Wu C and Jiang J: Prognostic role of tumor-infiltrating lymphocytes
in lung cancer: A meta-analysis. Cell Physiol Biochem.
37:1560–1571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li J, Chen L, Xiong Y, Zheng X, Xie Q,
Zhou Q, Shi L, Wu C, Jiang J and Wang H: Knockdown of PD-L1 in
human gastric cancer cells inhibits tumor progression and improves
the cytotoxic sensitivity to CIK therapy. Cell Physiol Biochem.
41:907–920. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zou W and Chen L: Inhibitory B7-family
molecules in the tumour microenvironment. Nat Rev Immunol.
8:467–477. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee HJ, Kim JY, Park IA, Song IH, Yu JH,
Ahn JH and Gong G: Prognostic significance of tumor-infiltrating
lymphocytes and the tertiary lymphoid structures in HER2-positive
breast cancer treated with adjuvant trastuzumab. Am J Clin Pathol.
144:278–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gu-Trantien C, Migliori E, Buisseret L, de
Wind A, Brohée S, Garaud S, Noël G, Dang Chi VL, Lodewyckx JN,
Naveaux C, et al: CXCL13-producing TFH cells link immune
suppression and adaptive memory in human breast cancer. JCI
Insight. 2:e914872017. View Article : Google Scholar
|
|
37
|
Schweiger T, Berghoff AS, Glogner C,
Glueck O, Rajky O, Traxler D, Birner P, Preusser M, Klepetko W and
Hoetzenecker K: Tumor-infiltrating lymphocyte subsets and tertiary
lymphoid structures in pulmonary metastases from colorectal cancer.
Clin Exp Metastasis. 33:727–739. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Im SJ, Hashimoto M, Gerner MY, Lee J,
Kissick HT, Burger MC, Shan Q, Hale JS, Lee J, Nasti TH, et al:
Defining CD8+ T cells that provide the proliferative burst after
PD-1 therapy. Nature. 537:417–421. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hornquist E, Grdic D, Mak T and Lycke N:
CD8-deficient mice exhibit augmented mucosal immune responses and
intact adjuvant effects to cholera toxin. Immunology. 87:220–229.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shalapour S, Font-Burgada J, Di Caro G,
Zhong Z, Sanchez-Lopez E, Dhar D, Willimsky G, Ammirante M,
Strasner A, Hansel DE, et al: Immunosuppressive plasma cells impede
T-cell-dependent immunogenic chemotherapy. Nature. 521:94–98. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shalapour S, Lin XJ, Bastian IN, Brain J,
Burt AD, Aksenov AA, Vrbanac AF, Li W, Perkins A, Matsutani T, et
al: Inflammation-induced IgA+ cells dismantle anti-liver cancer
immunity. Nature. 551:340–345. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lampropoulou V, Hoehlig K, Roch T, Neves
P, Calderón Gómez E, Sweenie CH, Hao Y, Freitas AA, Steinhoff U,
Anderton SM and Fillatreau S: TLR-activated B cells suppress T
cell-mediated autoimmunity. J Immunol. 180:4763–4773. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ayala VI, Deleage C, Trivett MT, Jain S,
Coren LV, Breed MW, Kramer JA, Thomas JA, Estes JD, Lifson JD and
Ott DE: CXCR5-dependent entry of CD8 T cells into rhesus macaque
B-Cell follicles achieved through T-cell engineering. J Virol.
91:2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li S, Folkvord JM, Rakasz EG, Abdelaal HM,
Wagstaff RK, Kovacs KJ, Kim HO, Sawahata R, MaWhinney S, Masopust
D, et al: Simian immunodeficiency virus-producing cells in
follicles are partially suppressed by CD8+ cells in vivo. J Virol.
90:11168–11180. 2016. View Article : Google Scholar : PubMed/NCBI
|
